US 12,145,911 B2
Inhibitors of cysteine proteases and methods of use thereof
Lee D. Arnold, Rancho Santa Fe, CA (US); Andy Jennings, San Diego, CA (US); and Walter Keung, Encinitas, CA (US)
Assigned to Pardes Biosciences, Inc., Carlsbad, CA (US)
Filed by Pardes Biosciences, Inc., Carlsbad, CA (US)
Filed on May 31, 2022, as Appl. No. 17/828,881.
Application 17/828,881 is a continuation of application No. 17/525,514, filed on Nov. 12, 2021, granted, now 11,524,940.
Application 17/525,514 is a continuation of application No. 17/322,221, filed on May 17, 2021, granted, now 11,174,231, issued on Nov. 16, 2021.
Claims priority of provisional application 63/179,128, filed on Apr. 23, 2021.
Claims priority of provisional application 63/173,146, filed on Apr. 9, 2021.
Claims priority of provisional application 63/172,478, filed on Apr. 8, 2021.
Claims priority of provisional application 63/171,675, filed on Apr. 7, 2021.
Claims priority of provisional application 63/129,018, filed on Dec. 22, 2020.
Claims priority of provisional application 63/091,630, filed on Oct. 14, 2020.
Claims priority of provisional application 63/067,669, filed on Aug. 19, 2020.
Claims priority of provisional application 63/039,297, filed on Jun. 15, 2020.
Claims priority of provisional application 63/036,866, filed on Jun. 9, 2020.
Prior Publication US 2024/0270693 A1, Aug. 15, 2024
Int. Cl. C07D 213/90 (2006.01); A61K 31/445 (2006.01); A61K 45/06 (2006.01)
CPC C07D 213/90 (2013.01) [A61K 45/06 (2013.01)] 4 Claims
 
1. A compound represented by:

OG Complex Work Unit Chemistry